Invesco
AYTU icon

Invesco’s AYTU BioPharma AYTU Stock Holding History

Invesco’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3
Closed -$3K – 3889
2018
Q2 		$3K Buy
+3
New +$5K ﹤0.01% 3872

Other funds holding AYTU

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Invesco's AYTU Position: Q3 2018 in Review

Invesco sold out of AYTU BioPharma (AYTU) in Q3 2018, closing a stake of 3 shares — an estimated $3K sold.

Invesco first reported a position in AYTU in Q2 2018 and held it in 1 quarter. The position peaked at $3K in Q2 2018. 8 funds tracked by Wall St. Rank hold AYTU as of Q3 2018.

  • Invesco reported no remaining AYTU BioPharma position as of Q3 2018 after selling out during the quarter.
  • Invesco sold 3 AYTU BioPharma shares in Q3 2018, an estimated $3K.
  • Invesco first reported a position in AYTU BioPharma in Q2 2018 and held it in 1 quarter.
  • Invesco's AYTU BioPharma position peaked at $3K in Q2 2018.
  • 8 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2018.

Based on Invesco's 13F filing for Q3 2018, filed 14 Nov 2018.